Cen Xu has extensive work experience in the pharmaceutical industry. They started their career at Bristol-Myers Squibb Company in 1998 as a Sr. Research Investigator, working there until 2006. In 2006, Cen Xu joined Amgen as an Executive Medical Director and held this role for 15 years until 2021. Currently, they are the Chief Scientific Officer at AffaMed Therapeutics.
Cen Xu obtained a Doctor of Philosophy (PhD) in Pharmacology from Illinois State University in 1996.
May, 2021 - present
EVP, Research & Development & Chief Scientific Officer at AbbVie
Chief Scientific Officer at Rhythm AI
President Of Research & Development And Chief Scientific Officer at Karuna Therapeutics
Chief Scientific Officer at Calico
Chief Scientific Officer, Consumer Health & Executive Board Member at Bayer
Access the worlds's biggest network of public org charts
Learn more